Vaccine

Details for Australian Patent Application No. 2006239471 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Dubin, Gary; Wettendorff, Martine Anne Cecile; Slaoui, Moncef Mohammed; Innis, Bruce

Agent Shelston IP

Pub. Number AU-A-2006239471

PCT Pub. Number WO2006/114273

Priority 11/114,301 26.04.05 US; PCT/ EP2005/006461 14.06.05 EP; 11/367,601 16.12.05 US

Filing date 24 April 2006

Wipo publication date 2 November 2006

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/114273 Priority application(s): WO2006/114273

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239493-Phase control

2006239444-New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents